PATENT CLAIM ANALYSIS

Application Number: 16033690
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "450000"]

Abstract:
Provided, among other things, is a method of treating or ameliorating pulmonary infection in a cystic fibrosis patient comprising pulmonary administration of an effective amount of a liposomal/complexed antiinfective to the patient, wherein the (i) administrated amount is 50% or less of the comparative free drug amount, or (ii) the dosing is once a day or less, or (iii) both.

Claim (Index 14):
The method of treating or ameliorating of  claim 1 , wherein the infection to be treated or ameliorated is a  pseudomonas  (e.g.,  P. aeruginosa, P. paucimobilis, P. putida, P. fluorescens , and  P. acidovorans ), staphylococcal, Methicillin-resistant  Staphylococcus aureus  (MRSA), streptococcal (including by  Streptococcus pneumoniae ),  Escherichia coli, Klebsiella, Enterobacter, Serratia, Haemophilus, Yersinia pestis, Burkholderia pseudomallei, B. cepacia, B. gladioli, B. multivorans, B. vietnamiensis, Mycobacterium tuberculosis, M. avium  complex (MAC) ( M. avium  and  M. intracellulare ),  M. kansasii, M. xenopi, M. marinum, M. ulcerans , or  M. fortuitum  complex ( M. fortuitum  and  M. chelonei ) infection.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 95.0
- Lexical Diversity: 1.62222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10696389', '12748756', '13899457', '14319018', '15311488']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6774805299311109
- 35 USC 102 Novelty (BERT): 0.511201541156636
- Combined Prediction Score: 0.6608526310536634
- Mean Citation Score: 224.913598
- Max Citation Score: 275.5311
- Similarity Product: 192.35772890186905

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test